Susan L. Pendland

2.1k citations

46 papers · 1.4k indexed · h-index 20

Co-authors: Gail B. Mahady Zhi Lu Larry H. Danziger Lucas R. Chadwick Chad R. Messick Birgit M. Dietz Frank A. Hamill Daniel G. Fabricant
Topics: Antibiotics Pharmacokinetics and Efficacy (17 papers)Antibiotic Resistance in Bacteria (14 papers)Bacterial Identification and Susceptibility Testing (10 papers)
Cited by: Molecular Medicine Pharmacology Applied Microbiology and Biotechnology
Journals: Journal of Agricultural and Food Chemistry Journal of Clinical Microbiology Antimicrobial Agents and Chemotherapy
Partner nations: United States Belgium Peru

In The Last Decade

Susan L. Pendland

46 papers receiving 1.3k citations

Peers

Countries citing papers authored by Susan L. Pendland

Since Specialization

Citations

This map shows the geographic impact of Susan L. Pendland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan L. Pendland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan L. Pendland more than expected).

Fields of papers citing papers by Susan L. Pendland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan L. Pendland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan L. Pendland. The network helps show where Susan L. Pendland may publish in the future.

Co-authorship network of co-authors of Susan L. Pendland

This figure shows the co-authorship network connecting the top 25 collaborators of Susan L. Pendland. A scholar is included among the top collaborators of Susan L. Pendland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan L. Pendland. Susan L. Pendland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Standardized ginger (Zingiber officinale) extract reduces bacterial load and suppresses acute and chronic inflammation in Mongolian gerbils infected withcagA⁺Helicobacter pylori 2009 ·Pharmaceutical Biology ·(unknown),Yue Huang,Dawn A. Israel,Susan L. Pendland,Bolanle A. Adeniyi,Gail B. Mahady	29
2	Effects of cranberry extracts and ursolic acid derivatives on P-fimbriatedEscherichia coli, COX-2 activity, pro-inflammatory cytokine release and the NF-κβ transcriptional responsein vitro 2009 ·Pharmaceutical Biology ·Yue Huang,Dejan Nikolić,Susan L. Pendland,Brian J. Doyle,Tracie Locklear,Gail B. Mahady	56
3	The Effect of Temperature on the Antimicrobial Activity of Optisol-GS 2006 ·Cornea ·R. L. Kapur,Elmer Y. Tu,Susan L. Pendland,Richard G. Fiscella,Joel Sugar	19
4	In Vitro susceptibility ofHelicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders 2005 ·Phytotherapy Research ·Gail B. Mahady,Susan L. Pendland,(unknown),Frank A. Hamill,Daniel G. Fabricant,Birgit M. Dietz,Lucas R. Chadwick	173
5	Antimycobacterial evaluation of Peruvian plants 2003 ·Phytomedicine ·James G. Graham,Susan L. Pendland,(unknown),(unknown),Jose Schunke Vigo,Fernando Cabieses,Norman R. Farnsworth	22
6	In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis 2003 ·Phytotherapy Research ·Gail B. Mahady,Susan L. Pendland,(unknown),Lucas R. Chadwick	102
7	Effect of Perfluorooctyl Bromide on Bacterial Growth 2003 ·Chemotherapy ·Rose Jung,Susan L. Pendland,Steven J. Martin	2
8	Comparative killing rates of gatifloxacin and ciprofloxacin against 14 clinical isolates: impact of bacterial strain and antibiotic concentration 2002 ·Diagnostic Microbiology and Infectious Disease ·Susan L. Pendland,Melinda M. Neuhauser,Kevin W. Garey,(unknown),Rose Jung	5
9	In vitro bactericidal activity of ABT-773 and amoxicillin against erythromycin-susceptible and -resistant strains of Streptococcus pyogenes 2002 ·Journal of Antimicrobial Chemotherapy ·Susan L. Pendland,Melinda M. Neuhauser,(unknown)	5
10	Extended‐Spectrum β‐Lactamases: Frequency, Risk Factors, and Outcomes 2002 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown),Melinda M. Neuhauser,David T. Bearden,John P. Quinn,Susan L. Pendland	36
11	Cunninghamella bertholletiae Infection in a Bone Marrow Transplant Patient: Amphotericin Lung Penetration, MIC Determinations, and Review of the Literature 2001 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Kevin W. Garey,Susan L. Pendland,(unknown),(unknown),Gerard M. Jensen,Kenneth Pursell	25
12	Postantibiotic Effects of ABT-773 and Amoxicillin-Clavulanate against Streptococcus pneumoniae and Haemophilus influenzae 2001 ·Antimicrobial Agents and Chemotherapy ·Melinda M. Neuhauser,(unknown),Larry H. Danziger,Susan L. Pendland	4
13	In Vitro Activities of a New Ketolide, ABT-773, Alone and in Combination with Amoxicillin, Metronidazole, or Tetracycline against Helicobacter pylori 2000 ·Antimicrobial Agents and Chemotherapy ·Susan L. Pendland,(unknown),Melinda M. Neuhauser,(unknown),(unknown),Larry H. Danziger	8
14	Modified time–kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinations 1999 ·Journal of Antimicrobial Chemotherapy ·Chad R. Messick,Keith A. Rodvold,Susan L. Pendland	13
15	Levofloxacin and Sparfloxacin: New Quinolone Antibiotics 1998 ·Annals of Pharmacotherapy ·Steven J. Martin,(unknown),Susan K. Chuck,Rose Jung,Chad R. Messick,Susan L. Pendland	44
16	In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci 1998 ·Diagnostic Microbiology and Infectious Disease ·Chad R. Messick,(unknown),Susan L. Pendland	1
17	In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: Enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin 1997 ·Diagnostic Microbiology and Infectious Disease ·Steven J. Martin,Susan L. Pendland,Connie L. Chen,Paul C. Schreckenberger,Larry H. Danziger	8
18	In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci 1997 ·Diagnostic Microbiology and Infectious Disease ·Chad R. Messick,Susan L. Pendland	17
19	Polyhexamethylene Biguanide (PHMB) in the Treatment of Experimental Fusarium Keratomycosis 1997 ·Cornea ·Richard G. Fiscella,(unknown),Chad R. Messick,Susan L. Pendland,John Chandler,Marlos A. G. Viana	19
20	In-vitro activity of a new oral streptogramin, RPR 106972, alone and in combination with rifampicin or ciprofloxacin against Legionella spp 1997 ·Journal of Antimicrobial Chemotherapy ·Susan L. Pendland	3

About Susan L. Pendland

Susan L. Pendland is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 46 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (14 papers) and Bacterial Identification and Susceptibility Testing (10 papers). The work is most often cited by research in Molecular Medicine (283 citations), Pharmacology (258 citations) and Applied Microbiology and Biotechnology (46 citations). Susan L. Pendland has collaborated with scholars based in United States, Belgium and Peru. Frequent co-authors include Gail B. Mahady, Zhi Lu, Larry H. Danziger, Lucas R. Chadwick, Chad R. Messick, Birgit M. Dietz, Frank A. Hamill, Daniel G. Fabricant, Manjunath P. Pai and Norman R. Farnsworth. Their work appears in journals such as Journal of Agricultural and Food Chemistry, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact